MALIGNANT PLEURAL EFFUSIONS (MPE)
Clinical trials for MALIGNANT PLEURAL EFFUSIONS (MPE) explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PLEURAL EFFUSIONS (MPE) trials appear
Sign up with your email to follow new studies for MALIGNANT PLEURAL EFFUSIONS (MPE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Herbal mix and cancer drug join forces to fight fluid in lungs
Disease control Not yet recruitingThis study tests whether adding a Chinese herbal formula (Xuanyin Ning) to a standard cancer drug (bevacizumab) can better control malignant pleural effusion—fluid buildup in the chest caused by advanced lung cancer. About 308 participants will receive either the herbal formula o…
Matched conditions: MALIGNANT PLEURAL EFFUSIONS (MPE)
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
New injection aims to ease breathing in cancer patients with Fluid-Filled lungs
Symptom relief Not yet recruitingThis study tests a new drug, JMKX000197, against a standard chemotherapy drug (cisplatin) to see which works better at controlling fluid buildup around the lungs in people with advanced cancer. About 120 participants with moderate to large fluid collections will receive the drug …
Matched conditions: MALIGNANT PLEURAL EFFUSIONS (MPE)
Phase: PHASE2 • Sponsor: Shanghai Jeyou Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC